Trial Profile
This will be a prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter, interventional study.
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 25 Jun 2018
Price :
$35
*
At a glance
- Drugs Heparin (Primary)
- Indications Thrombophlebitis
- Focus Therapeutic Use
- Sponsors Troikaa Pharmaceuticals
- 25 Jun 2018 New trial record